UnknownNot Applicable

Study of Oro-cecal Transit Time in Healthy Subjects Using Scintigraphy and Lactulose Hydrogen Breath Test.

India50 participantsStarted 2021-07-01

Plain-language summary

Radionuclide scintigraphy is the gold standard technique to interpret OCTT but there is no normative data available for its interpretation in Indian population. Previous studies to determine OCTT have all been done with LHBT, which has many limitations. Besides there are few small comparative studies between scintigraphy and LHBT, that too not in Indian population. The aim of this study is to validate LHBT to measure OCTT compared with scintigraphy and to standardize the normal OCTT in healthy individuals

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: • Healthy individual \> 18 years of age with no comorbidities Exclusion Criteria: * Thoracic or digestive foregut surgery, * Alcohol consumption \>40 g/day, * Use of medications that alter intragastric acidity or oesophageal motility * History of diabetes mellitus, thyroid disorder * Neurological disorders * Chronic gastrointestinal disease * Any subject with upper GI symptoms like pain, burning, belching, bloating, dysphagia \& aerophagia

What they're measuring

Oro-caecal transit time (OCTT) using lactulose hydrogen breath test (LHBT) and scintigraphy study.

Timeframe: six months

Trial details

NCT IDNCT05004207

SponsorAsian Institute of Gastroenterology, India

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-01-31

Contact for this trial

Neeraj Singla, MBBS, MD, DM

7888619216 dr.neerajsingla@gmail.com

View on ClinicalTrials.gov More Small Bowel Disease trials